407272 Sigma-AldrichIntegrin αvβ3 Antagonist, P11 - Calbiochem
The Integrin αvβ3 Antagonist, P11 controls the biological activity of Integrin αvβ3.
More>> The Integrin αvβ3 Antagonist, P11 controls the biological activity of Integrin αvβ3. Less<<Synonyms: HSDVHK-NH2, HSDVHK
Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| Empirical Formula | 
|---|
| C₃₀H₅₁N₁₂O₉₃· 3TFA | 
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 407272-5MGCN | 
  |  
Glass bottle | 5 mg | 
  | 
— | 
| References | |
|---|---|
| References | Bang, J., et al. 2011. Mol Cell Proteomics 10, M110. Choi, Y., et al. 2010. Proteomics 10, 72. Lee, Y., et al. 2004. J. Biomol. Screen. 9, 687.  | 
| Product Information | |
|---|---|
| Form | White solid | 
| Formulation | Supplied as a trifluoracetate salt. | 
| Hill Formula | C₃₀H₅₁N₁₂O₉₃· 3TFA | 
| Chemical formula | C₃₀H₅₁N₁₂O₉₃· 3TFA | 
| Structure formula Image | |
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Purity | ≥95% by HPLC | 
| Physicochemical Information | 
|---|
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN | 
| 407272-5MGCN | 04055977188769 | 
Documentation
Integrin αvβ3 Antagonist, P11 - Calbiochem SDS
| Title | 
|---|
Integrin αvβ3 Antagonist, P11 - Calbiochem Certificates of Analysis
| Title | Lot Number | 
|---|---|
| 407272 | 
References
| Reference overview | 
|---|
| Bang, J., et al. 2011. Mol Cell Proteomics 10, M110. Choi, Y., et al. 2010. Proteomics 10, 72. Lee, Y., et al. 2004. J. Biomol. Screen. 9, 687.  | 



  
